International Standard Serial Number (ISSN)
publication venue for
Neuropsychological course in the prodrome and first episode of psychosis: findings from the PRIME North America Double Blind Treatment Study.
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.
A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.
Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia.
Olanzapine and haloperidol in first episode psychosis: two-year data.
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
M50 sensory gating predicts negative symptoms in schizophrenia.
An excitement subscale of the Positive and Negative Syndrome Scale.
First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol.
Treatment of rats with antipsychotic drugs: lack of an effect on brain N-acetyl aspartate levels.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design.
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure.
First-episode schizophreniform disorder: comparisons with first-episode schizophrenia.
Racial differences in the diagnosis of psychosis.
The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.
The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.